Welcome to our dedicated page for MOTLY news (Ticker: MOTLY), a resource for investors and traders seeking the latest updates and insights on MOTLY stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MOTLY's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MOTLY's position in the market.
MetaOptics (MOTLY) established a sponsored Level 1 American depositary receipt (ADR) programme on September 24, 2026, with OTCQX trading to follow.
J.P. Morgan is the depositary bank, and American depositary shares (ADSs) will trade on the U.S. market. The programme involves no capital raising or issuance of new shares. MetaOptics’ ordinary shares will continue trading on the Singapore Exchange’s Catalist board, and the company does not expect a material impact on existing shareholders.
MetaOptics intends the programme to give U.S. investors a more convenient way to trade its securities as it expands its U.S. activities.